Synapse News

2 of 26

Two Hamilton innovators win national Arthritis Ideator Awards

Two Hamiltonians were among 4 winners (and eight finalists) in a national competition which provides funding for innovative projects that help people suffering from arthritis. The Arthritis Ideator Program — run by the Arthritis Society — received 21 submissions from innovators, entrepreneurs, and startups across Canada working on…

April 21, 2022 | Alex Muggah

McMaster Seed Fund supports two startups in first round of funding with $735,000

Two McMaster startups – Syndemix and Insight Medbotics – have received a combined  $735,000 to move their innovations closer to reality in the first round of investments of the McMaster Seed Fund. Synmedix — a biotechnology company founded by Eric Brown, Distinguished University Professor of biochemistry and biomedical sciences —…

April 20, 2022 | Alex Muggah

Ontario invests $40 million to grow global life sciences sector at Hamilton’s McMaster Innovation Park

Hamilton could become the “catalyst” that will see Ontario become a global hub for biomanufacturing and life sciences growth. Invest Ontario is providing OmniaBio Inc. with about $40 million in a loan as part of a new $580-million biomanufacturing facility at McMaster Innovation Park on Longwood Road. The goal for the Ontario government…

April 4, 2022 | Alex Muggah

Ontario economic development minister Announces $40M investment in Hamilton’s OmniaBio (video)

Vic Fedeli, Minister of Economic Development, Job Creation and Trade, was joined by Prabmeet Sarkaria, President of the Treasury Board, and Donna Skelly, MPP for Flamborough—Glanbrook, to make an announcement at McMaster Innovation Park

March 31, 2022 | Alex Muggah

Invest Ontario Supports New Biomanufacturing Facility in Hamilton

Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation while advancing pioneering medicine with the potential to cure, not just treat, many forms of cancer, cardiovascular diseases, Parkinson’s and diabetes. OmniaBio, a Canadian cell and gene…

March 31, 2022 | Alex Muggah

New gene- and cell-therapy manufacturing facility to launch in Hamilton with $580-million commitment

Ontario says it will provide a $40-million loan to the Centre for Commercialization of Regenerative Medicine for its planned $580-million Hamilton facility where life-science companies can develop and commercialize cell and gene therapies. The CCRM, a non-profit industry group, said Thursday that the facility will be run by a new subsidiary…

March 31, 2022 | Alex Muggah

Triumvira Immunologics Completes Extension of Series A Financing, for Total Round of Approximately $100 Million

Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors, today announced the completion of an extension of its Series A financing, bringing the total round to approximately $100 million. The Series A…

March 17, 2022 | Alex Muggah

Dr. Marc Jeschke named new VP of Research at HHS

Hamilton Health Sciences Centre has announced the appointment of Dr. Marc Jeschke (pictured) as vice president of research at HHS, commencing on June 1, 2022. Dr. Jeschke brings world-renowned expertise to the organization in the field of translational research through which basic scientific and medical research are brought into day-to-day…

January 26, 2022 | Alex Muggah

McMaster ranked #1 for faculty and graduate student research intensity

McMaster University continues to rank among the country’s most research-intensive universities – for both graduate students and faculty members – in the annual ranking of the country’s Top 50 Research Universities. According to the 2021 Research Infosource rankings released today, McMaster placed first in graduate student research…

January 25, 2022 | Alex Muggah